1 – 91 of 91
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Delays in dealing with complaints against drug companies are growing, BMJ finds
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Patterns of company misconduct, recidivism, and complaint resolution delays : A temporal analysis of UK pharmaceutical industry self-regulation within the European context
2024) In Regulation and Governance(
- Contribution to journal › Article
-
Mark
Evaluating time to withdrawal of anti-cancer drug indications that received FDA's accelerated approval
2024) In QJM - Monthly Journal of the Association of Physicians(
- Contribution to journal › Letter
-
Mark
Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States : A comparative study of accelerated approvals
(
- Contribution to journal › Article
-
Mark
Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019 : An observational study
(
- Contribution to journal › Article
-
Mark
Broken beyond repair: self regulation of industry payments to clinicians and hospitals
(
- Contribution to journal › Debate/Note/Editorial
- 2023
-
Mark
Conceptual unclarity about COVID-19 ethnic disparities in Sweden: Implications for public health policy
(
- Contribution to journal › Article
-
Mark
Pharmaceutical industry payments to NHS trusts in England : A four-year analysis of the Disclosure UK database
(
- Contribution to journal › Article
-
Mark
Authors’ reply to Fell
(
- Contribution to journal › Letter
-
Mark
Unethical pharmaceutical marketing: a common problem requiring collective responsibility
(
- Contribution to journal › Article
-
Mark
Race in clinical trials in Sweden: how regulatory and medical standards in clinical research trump the post-racial discourse
2023) In Sociology of Health & Illness(
- Contribution to journal › Article
-
Mark
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
(
- Contribution to journal › Article
-
Mark
Short-circuiting biology: Digital phenotypes, digital biomarkers, and shifting gazes in psychiatry
2023) In Big Data and Society(
- Contribution to journal › Article
- 2022
-
Mark
A “patient-industry complex”? Investigating the financial dependency of UK patient organisations on drug company funding
(
- Contribution to journal › Article
-
Mark
Tip of the iceberg? Country- and company-level analysis of drug company payments for research and development in Europe
(
- Contribution to journal › Article
-
Mark
The making of a Swedish strategy : How organizational culture shaped the Public Health Agency's pandemic response
(
- Contribution to journal › Article
-
Mark
Capitalizing on transparency: commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act
(
- Contribution to journal › Article
-
Mark
Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
(
- Contribution to journal › Article
-
Mark
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation
2022) In BioSocieties(
- Contribution to journal › Article
-
Mark
Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark
(
- Contribution to journal › Article
-
Mark
Content and strength of conflict of interest policies at Scandinavian Medical Schools: a cross sectional study
(
- Contribution to journal › Article
-
Mark
De unga gör helt rätt när de stämmer staten
2022) In Aftonbladet(
- Contribution to specialist publication or newspaper › Newspaper article
- 2021
-
Mark
Sweden
2021)(
- Chapter in Book/Report/Conference proceeding › Chapter in report
-
Mark
Failure of responsive regulation? : Pharmaceutical marketing, corporate impression management and off-label promotion of enzalutamide in Europe
(
- Contribution to journal › Article
-
Mark
Drug company payments to General Practices in England: cross-sectional and social network analysis
(
- Contribution to journal › Article
-
Mark
Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: A European policy review
(
- Contribution to journal › Article
-
Mark
Data Transparency and Pharmaceutical Regulation in Europe : Road to Damascus, or Room without a View?
2021) p.63-94(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Pharmaceutical industry self-regulation and non-transparency : country and company level analysis of payments to healthcare professionals in seven European countries
(
- Contribution to journal › Article
-
Mark
Is there evidence for the racialization of pharmaceutical regulation? : Systematic comparison of new drugs approved over five years in the USA and the EU
(
- Contribution to journal › Article
-
Mark
Sociologisk forskning om covid-19-pandemin : En introduktion
(
- Contribution to journal › Debate/Note/Editorial
- 2020
-
Mark
The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza
(
- Contribution to journal › Article
-
Mark
Revisiting the pharmaceuticalisation of pandemic influenza using Lukes’ framework of power
(
- Contribution to journal › Article
-
Mark
Sociologiska perspektiv på coronakrisen : Fyra sociologer om samhällets reaktion på covid-19
(
- Contribution to journal › Letter
-
Mark
Bengt Olle Bengtsson intervjuad av Shai Mulinari : Om genetisk likhet och skillnad
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Ras i genetikens tidevarv
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Svenska gener? : Om stratifierad precisionsmedicin och genetikens etniska gränsdragningar
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Pharmaceutical lobbying and pandemic stockpiling : A feeling of déjà vu in the Nordic countries and why the sociological perspective is crucial to understand COVID-19
(
- Contribution to journal › Article
-
Mark
Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016)
(
- Contribution to journal › Article
-
Mark
Ras och genetiska skillnader : Introduktion till avsnittets texter
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Five years of pharmaceutical industry funding of patient organisations in Sweden: cross-sectional study of companies, patient organisations and drugs
2020) In PLoS ONE(
- Contribution to journal › Article
- 2019
-
Mark
Exposing drug industry funding of UK patient organisations
(
- Contribution to journal › Article
-
Mark
The whistleblowing drama behind Astellas’s suspension from the ABPI
(
- Contribution to journal › Letter
-
Mark
Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK
(
- Contribution to journal › Article
-
Mark
Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
(
- Contribution to journal › Article
- 2018
-
Mark
Explaining biological depression theories
(
- Contribution to journal › Letter
-
Mark
Let the drugs lead the way! : On the unfolding of a research programme in psychiatry
(
- Contribution to journal › Article
-
Mark
Categorical and anti-categorical approaches to US racial/ethnic groupings: revisiting the National 2009 H1N1 Flu Survey (NHFS)
(
- Contribution to journal › Article
-
Mark
Overuse of methylphenidate : an analysis of Swedish pharmacy dispensing data
(
- Contribution to journal › Article
-
Mark
Disclosure of payments by pharmaceutical companies to healthcare professionals in the United Kingdom: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
(
- Contribution to journal › Article
-
Mark
Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny
(
- Contribution to journal › Letter
-
Mark
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
(
- Contribution to journal › Article
-
Mark
Chronic Obstructive Pulmonary Disease in Sweden: an intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy
(
- Contribution to journal › Article
-
Mark
Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics
(
- Contribution to journal › Article
-
Mark
Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden
(
- Contribution to journal › Article
- 2017
-
Mark
Intersektionalitet och risk för ischemisk hjärtsjukdom i Sverige
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
An intersectional approach to multilevel analysis of individual heterogeneity (MAIH) and discriminatory accuracy
(
- Contribution to journal › Article
-
Mark
Intersectionality and risk for ischemic heart disease in Sweden: Categorical and anti-categorical approaches
(
- Contribution to journal › Article
-
Mark
Two thirds of Survey Respondents in Southern Sweden used Complementary or Alternative Medicine (CAM) in 2015
(
- Contribution to journal › Article
-
Mark
Intersectionality and risk of ischemic heart disease in Sweden: categorical and anti-categorical approaches
2017) IEA World Congress of Epidemiology 2017(
- Contribution to conference › Other
-
Mark
Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews
(
- Contribution to journal › Article
-
Mark
The tyranny of the averages and the indiscriminate use of risk factors in public health : The case of coronary heart disease
(
- Contribution to journal › Article
- 2016
-
Mark
Regulating Pharmaceutical Industry Marketing: Development, Enforcement and Outcome of Marketing Rules
(
- Contribution to journal › Article
-
Mark
Contemporary Epidemiology : A Review of Critical Discussions Within the Discipline and A Call for Further Dialogue with Social Theory
(
- Contribution to journal › Article
-
Mark
Unhealthy marketing of pharmaceutical products: An international public health concern
(
- Contribution to journal › Article
-
Mark
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
(
- Contribution to journal › Article
-
Mark
Appropriate assessment of ethnic differences in adolescent use of psychotropic medication: multilevel analysis of discriminatory accuracy.
(
- Contribution to journal › Article
-
Mark
Testosterone prescribing in the population-a short social epidemiological analysis in Sweden.
(
- Contribution to journal › Article
-
Mark
Användning av alternativ och komplementär medicin (AKM) i Skåne: Pilotstudie 2016
2016)(
- Book/Report › Report
-
Mark
Hail the Tattletale
(
- Contribution to specialist publication or newspaper › Newspaper article
- 2015
-
Mark
Does Maternal Country of Birth Matter for Understanding Offspring’s Birthweight? A Multilevel Analysis of Individual Heterogeneity in Sweden
(
- Contribution to journal › Article
-
Mark
Många allvarliga brott mot regler när läkemedel marknadsförs
(
- Contribution to journal › Letter
-
Mark
Divergence and convergence of commercial and scientific priorities in drug development: the case of Zelmid, the first SSRI antidepressant
(
- Contribution to journal › Article
-
Mark
Questioning the discriminatory accuracy of broad migrant categories in public health: self-rated health in Sweden
(
- Contribution to journal › Article
-
Mark
Measures of discriminatory accuracy and categorizations in public health: a response to Allan Krasnik's editorial.
(
- Contribution to journal › Letter
-
Mark
Money, Money, Money? Politico-Moral Discourses of Stem Cell Research in a Grant Allocation Process
(
- Contribution to journal › Article
-
Mark
Etik och marknadsföring: Skäl till självkritik?
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Replik, etik och marknadsföring: Inte för sent för reformer
(
- Contribution to journal › Letter
-
Mark
Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation
(
- Contribution to journal › Article
- 2014
-
Mark
The specificity triad: notions of disease and therapeutic specificity in biomedical reasoning
(
- Contribution to journal › Article
- 2013
-
Mark
Misleading advertising for antidepressants in sweden: a failure of pharmaceutical industry self-regulation.
(
- Contribution to journal › Article
-
Mark
Regulating drug information in Europe: a pyrrhic victory for pharmaceutical industry critics?
(
- Contribution to journal › Article
- 2012
-
Mark
Slapp hantering av läkemedelsindustrin skadar Läkemedelsverkets trovärdighet
(
- Contribution to journal › Letter
-
Mark
Genetics and democracy-what is the issue?
2012) In Journal of Community Genetics(
- Contribution to journal › Article
-
Mark
Monoamine theories of depression: historical impact on biomedical research
(
- Contribution to journal › Article
-
Mark
Regulating drug information in Europe: a pyrrhic victory for countervailing forces?
2012) ISA Forum of Sociology Social justice and democratization, 2012(
- Contribution to conference › Abstract
- 2011
-
Mark
Varför fara med osanningar om depressioners orsaker?
(
- Contribution to journal › Letter
- 2010
-
Mark
Rho-guanine nucleotide exchange factors during development: Force is nothing without control.
(
- Contribution to journal › Article
- 2009
-
Mark
Hedgehog, but not Odd skipped, induces segmental grooves in the Drosophila epidermis.
(
- Contribution to journal › Article
- 2008
-
Mark
From Cell Shape to Body Shape: Epithelial Morphogenesis in Drosophila melanogaster
(
- Thesis › Doctoral thesis (compilation)
-
Mark
DRhoGEF2 and Diaphanous Regulate Contractile Force during Segmental Groove Morphogenesis in the Drosophila Embryo.
(
- Contribution to journal › Article
- 2006
-
Mark
Expression and regulation of Spätzle-processing enzyme in Drosophila.
(
- Contribution to journal › Article